Abstract
We studied the effects of transcranial magnetic stimulation (TMS, 60 Hz and 0.7 mT for 4 h/day for 14 days) on oxidative and cell damage caused by olfactory bulbectomy (OBX) in Wistar rats. The levels of lipid peroxidation products and caspase-3 were enhanced by OBX, whereas it prompted a reduction in reduced glutathione (GSH) content and antioxidative enzymes activities. The treatment with TMS reverted towards normality the biomarkers indicative of oxidative stress and apoptosis. In conclusion, our data show that TMS induced a protection against cell and oxidative damage induced by OBX, as well as they support the hypothesis that oxidative stress may play an important role in depression.
Similar content being viewed by others
References
Murray CJ, López AD (1997) Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349:1498–1504
Akiskal HS (2005) Searching for behavioural indicators of bipolar II in patients presenting with major depressive episodes: the “red sign”, the “rule of three” and other biographic signs of temperamental extravagance, activation and hypomania. J Affect Disord 84:279–290
Freitas C, Fregni F, Pascual-Leone A (2009) Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res 208:11–24
Nitsche MA, Boggio PS, Fregni F et al (2009) Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol 219:14–19
Arias-Carrión O, Verdugo-Díaz L, Deria-Velasco A et al (2004) Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions. J Neurosci Res 78:16–28
Johnston MV (2009) Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev 15:94–101
Ng F, Berk M, Dean O et al (2008) Oxidative stress in psychiatric disorders: evidence and therapeutic implications. Int J Neurophsychopharmacol 11:851–876
Tsaluchidu S, Cocchi M, Tonillo L et al (2008) Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8:S5
Rezin GT, Amboni G, Zugno AI et al (2009) Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34:1021–1029
López-Ibor JJ, López-Ibor MI, Pastrana JI (2008) Transcranial magnetic stimulation. Curr Opin Psychiatry 21:640–644
Machado S, Bittencourt J, Minc D et al (2008) Therapeutic applications of repetitive transcranial magnetic stimulation in clinical neurorehabilitation. Funct Neurol 23:113–122
Mathew SJ (2008) Treatment-resistant depression: recent developments and future directions. Depress Anxiety 25:989–992
Pallanti S, Bernardi S (2009) Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review. Int Clin Psychopharmacol 24:163–173
Zwanzger P, Fallgatter AJ, Zavorotnyy M et al (2009) Anxiolytic effects of transcranial magnetic stimulation—an alternative treatment option in anxiety disorders? J Neural Transm 116:767–775
Túnez I, Medina FJ, Jimena I et al (2007) Effect of fluoxetine on brain oxidative stress, neuronal damage and behavioural induced in the olfactory bulbectomy model of depression. Lett Drug Des Discov 4:305–310
Tasset I, Peña J, Feijóo M et al (2008) Effect of 17-beta estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. Neuropsychiatr Dis Treat 4:441–449
Túnez I, Drucker-Colín R, Jimena I et al (2006) Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington’s disease. J Neurochem 97:619–630
Túnez I, Montilla P, Muñoz MC et al (2006) Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. Neurosci Res 56:91–95
Vieyra-Reyes P, Mineur YS, Picciotto MR et al (2008) Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res Bull 77:13–18
Drucker-Colin R, Verdugo-Díaz L, Méndez M et al (1994) Comparison between low frequency magnetic field stimulation and nerve growth factor treatment of cultured chromaffin cells, on neurite growth, noradrenalina release, excitable proporties, and grafting in nigrostriatal lesioned rats. Mol Cell Neurosci 5:485–498
Feria-Velasco A, Castillo-Medina S, Verdugo-Díaz L et al (1998) Neuronal differentiation of chromaffin cells in vitro, induced by extremely low frequency magnetic fields or nerve growth factor: a histological and ultrastructural comparative study. J Neurosci Res 53:569–582
Arias-Carrión O (2008) Basic mechanisms of rTMS: implications in Parkinson’s disease. Int Arch Med 1:2
Flohé L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121
Bradford MM (1976) A rapid sensitive method for quantification of microgram quantities utilizing principle of protein-dye binding. Anal Biochem 72:248–254
Seth R, Jennings AL, Bindman J et al (1992) Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161:562–565
Galecki P, Szemraj J, Bienkiewicz M et al (2009) Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol 24:277–286
Kim do H, Li H, Yoo KY et al (2007) Effects of fluoxetine on ischemis cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia. Exp Neurol 204:748–758
Khanzode SD, Dakhale GN, Khanzode SS et al (2003) Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8:365–370
Zafir A, Banu N (2007) Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 572:23–31
Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146
Dryzga LR, Marcinowska A, Obuchowicz E (2009) Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res Bull 79:248–257
Maes M, Mihaylova I, Kubera M et al (2010) Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord. Doi: 10.1016/j.had.2009.12.014
Michel TM, Camara S, Tatschner T et al (2010) Increased xanthine oxidase in the thalamus and putamen in depression. World J Biol Psychiatry 11:314–320
Song C, Leonard BE (2005) The olfactory bulbectomized rats as a model of depression. Neurosci Biobehav Rev 29:627–647
Kodydková J, Vaávrová L, Zeman M et al (2009) Antioxidative enzymes and increased oxidative stress in depressive woman. Clin Biochem 42:1368–1374
Bilici M, Efe H, Köroglu MA et al (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51
Sarandol A, Sarandol E, Eker SS et al (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 22:67–73
Selek S, Savas HA, Gergerlioglu HS et al (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107:89–94
Zhao Z, Wang W, Guo H et al (2008) Antidepressant-like of liguiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 194:108–113
Tasset I, Medina FJ, Peña J et al (2010) Olfactory bulbectomy induced oxidative and cell damage in rat: protective effect of melatonin. Physiol Res 59:105–112
Robinson AM, Conley DB, Kern RC (2003) Olfactory neurons in bax knockout mice are protected from bulbectomy-induced apoptosis. Neuroreport 14:1891–1894
Szuster-Ciesielsk A, Slotwinska M, Stachura A et al (2008) Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:686–694
Gangadar NM, Firestein SJ, Stockwell BR (2008) A novel role for jun-N-terminal kinase signalling in olfactory sensory neuronal death. Mol Cell Neurosci 38:518–525
Borders AS, Getchell ML, Etscheidt JT et al (2007) Macrophage depletion in the murine olfactory epithelium leads to increased neuronal death and decreased neurogenesis. J Comp Neurol 501:206–218
Ihara Y, Takata H, Tanabe Y et al (2005) Influence of repetitive transcranial magnetic stimulation on disease severity and oxidative stress markers in the cerebrospinal fluid of patients with spinocerebellar degeneration. Neurol Res 27:310–313
Gao F, Wang S, Guo Y et al (2010) Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischemia: a microPET study. Eur J Nucl Med Mol Imaging 37:954–961
Ji RR, Schlaepfer TE, Aizenman CD et al (1998) Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci USA 95:15635–15640
Olivares-Bañuelos T, Navarro L, González A et al (2004) Differentiation of chromaffin cells elicited by ELF-MF modifies gene expresión pattern. Cell Biol Int 28:273–279
Fountoulaki KN, Grunze H, Panagiotidis P et al (2009) Treatment of bipolar depression: an update. J Affect Disord 109:21–34
Jeon WJ, Kim SH, Seo MS et al (2008) Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex. Exp Mol Med 31:435–444
Jornada LK, Feier G, Barichello T et al (2007) Effects of maintenance electroshock damage parameters in the rat brain. Neurochem Res 32:389–394
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tasset, I., Drucker-Colín, R., Peña, J. et al. Antioxidant-Like Effects and Protective Action of Transcranial Magnetic Stimulation in Depression Caused by Olfactory Bulbectomy. Neurochem Res 35, 1182–1187 (2010). https://doi.org/10.1007/s11064-010-0172-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-010-0172-9